Page last updated: 2024-12-07
4-(4'-chlorobenzyloxy)benzyl nicotinate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-(4'-chlorobenzyloxy)benzyl nicotinate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 124998 |
SCHEMBL ID | 1134809 |
MeSH ID | M0125247 |
Synonyms (10)
Synonym |
---|
(4-(4-chlorobenzyloxy)phenyl)methyl nicotinate |
3-pyridinecarboxylic acid, (4-((4-chlorophenyl)methoxy)phenyl)methyl ester |
kcd 232 |
4-(4'-chlorobenzyloxy)benzyl nicotinate |
kcd-232 |
[4-[(4-chlorophenyl)methoxy]phenyl]methyl pyridine-3-carboxylate |
63608-11-7 |
VAOFYKUGDPBCRA-UHFFFAOYSA-N |
SCHEMBL1134809 |
DTXSID40212988 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 7 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.37
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.37) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |